实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (2): 196-199.doi: 10.3969/j.issn.1672-5069.2019.02.011

• 病毒性肝炎 • 上一篇    下一篇

慢性丙型肝炎患者发生重度肝纤维化相关因素分析*

吴亚平,周冰清,蒋蓓莉   

  1. 223002 江苏省淮安市第四人民医院肝病科(吴亚平,周冰清);
    南京医科大学附属淮安第一医院感染性疾病科(蒋蓓莉)
  • 收稿日期:2018-06-20 出版日期:2019-03-10 发布日期:2019-03-19
  • 作者简介:吴亚平,男,51岁,大学本科,副主任医师。E-mail:swtsed@163.com
  • 基金资助:
    *南京医科大学科技发展基金项目(编号:2014NJMUZD024)

Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation

Wu Yaping, Zhou Bingqing, Jiang Peili   

  1. Department of Liver Diseases,Fourth People's Hospital,Huai’an,Jiangsu Province,China
  • Received:2018-06-20 Online:2019-03-10 Published:2019-03-19

摘要: 目的 探讨既往有有偿献血史的慢性丙型肝炎(CHC)患者发生重度肝纤维化的相关因素。方法 2015年1月~2017年12月于我院进行诊治的既往有有偿献血史的CHC患者248例,采用FIB-4指数对肝纤维化进行分期诊断,即将FIB-4指数>3.25定义为重度肝纤维化,FIB-4指数≤3.25定义为非重度肝纤维化。使用AU5800全自动生化分析仪检测血生化指标,采用RT-PCR法检测HCV RNA。采用单因素和多因素Logistic回归分析CHC患者发生重度肝纤维化的相关因素,计算比值比(OR)和95%可信区间(CI)。结果 经FIB-4指数评估,在本组248例既往有有偿献血史的CHC患者中,发现重度肝纤维化86例(34.7%),非重度肝纤维化162例(65.3%);单因素分析结果显示,两组人群文化程度、病程、家庭人均月收入、合并糖尿病、吸烟量、饮酒量、抗病毒治疗(干扰素联合利巴韦林治疗≥9个月)差异有统计学意义(P<0.05),而两组年龄、性别、合并高血压、合并HBV感染等差异无统计学意义(P>0.05);重度肝纤维化患者血清HCV RNA水平为(86250.4±673.7) IU/ml,与非重度肝纤维化患者的(86193.1±702.5) IU/ml比,差异无统计学意义(P>0.05),而空腹血糖水平为(6.8±1.3) mmol/L,谷丙转氨酶为(47.3±10.4) U/L,谷草转氨酶为(48.1±10.7) U/L,外周血白细胞计数为(3.8±1.0)×109/l, 与非重度肝纤维化组【分别为(5.9±1.1) mmol/L、(36.9±9.6) U/L、(35.6±10.1) U/L和(5.0±1.2)×109/l】比,差异具有显著的统计学意义(P<0.05);将单因素分析发现的有统计学差异的因素纳入多因素Logistic回归分析,结果显示,合并糖尿病(OR=1.982,P=0.002)、饮酒量≥50 g/d(OR=3.422,P=0.019)、病程长(OR=2.648,P=0.006)、家庭人均月收入<3000元(OR=2.413,P=0.029)、未进行抗病毒治疗(OR=4.733,P=0.030)为影响患者发生重度肝纤维化的独立危险因素(P<0.05)。结论 HCV感染往往呈慢性经过,感染者发生重度肝纤维化与多种因素有关,低收入人群不健康的生活方式、合并症的存在和不能有效地抗病毒治疗是既往有有偿献血史的CHC患者发生重度肝纤维化的独立危险因素,应予以高度重视。

关键词: 慢性丙型肝炎, 肝纤维化, 有偿献血史, 危险因素

Abstract: Objective To investigate the risk factors of severe hepatic fibrosis in patients with chronic hepatitis C(CHC) with previous paid blood donation. Methods 248 patients with CHC who had paid blood donation history were recruited in this study between January 2015 and December 2017. FIB-4 index was used to diagnose liver fibrosis,and we set the FIB-4 index greater than 3.25 as severe hepatic fibrosis and the FIB-4 index less than 3.25 as non-severe hepatic fibrosis. Univariate analysis of variance(ANOVA) and multivariate Logistic regression analysis were applied to analyze the risk factors of severe hepatic fibrosis in patients with CHC. Results Out of 248 patients with CHC and paid blood donation,86 cases(34.7%) had severe hepatic fibrosis,and 162 cases(65.3%) were non-severe hepatic fibrosis;univariate analysis showed that the ducation,course of disease,month income,concomitant diabetes mellitus,smoking,alcohol consumption and antiviral therapy (interferon-αplus ribavirin≥9 months) between the two groups were significantly different(P<0.05),while age,gender,concomitant blood hypertension,with hepatitis B viral coinfection were not significantly different(P>0.05);serum HCV RNA load in patient with severe hepaitc fibrosis was(86250.4±673.7) IU/ml,no significantly different as compared to (86193.1±702.5)IU/ml in patients without severe hepatic fibrosis (P>0.05),while fasting blood glucose level was (6.8±1.3) mmol/L,serum ALT level was (47.3±10.4)U/L,AST level was(48.1±10.7) U/L,and peripheral white blood cell count was(3.8±1.0)×109/l,significanyly different as compared to[(5.9±1.1) mmol/L,(36.9±9.6) U/L,(35.6±10.1) U/L and(5.0±1.2)×109/l,respectively,P<0.05】 in patients without severe hepatic fibrosis;multivariate Logistic regression analysis showed that concomitant diabetes mellitus(OR=1.982,P=0.002),alcohol consumption(OR=3.422,P=0.019),long course of disease(OR=2.648,P=0.006),month income (OR=2.413,P=0.029),and without antiviral therapy(OR=4.733,P=0.030) were the independent risk factors for severe hepatic fibrosis in patients with CHC and previous paid blood donation. Conclusion Hepatitis C infection tends to be a chronic process,which might induce liver fibrosis. The individuals with HCV infection could have severe hepatitis fibrosis if they had unhealthy life style, concomitant diseases and couldn’t afford antiviral therapy. The clinicians must pay more attention to them.

Key words: Hepatitis C, Hepatic fibrosis, Paid blood donation, Risk factors